Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity Study of SB16 in Healthy Male Subjects

NCT04621318 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Denosumab

Sponsor

Samsung Bioepis Co., Ltd.